CADL
Price
$6.22
Change
+$0.09 (+1.47%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
336.53M
71 days until earnings call
Intraday BUY SELL Signals
CRSP
Price
$56.89
Change
+$0.71 (+1.26%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
5.35B
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CADL vs CRSP

Header iconCADL vs CRSP Comparison
Open Charts CADL vs CRSPBanner chart's image
Candel Therapeutics
Price$6.22
Change+$0.09 (+1.47%)
Volume$12.21K
Capitalization336.53M
CRISPR Therapeutics AG
Price$56.89
Change+$0.71 (+1.26%)
Volume$26.2K
Capitalization5.35B
CADL vs CRSP Comparison Chart in %
View a ticker or compare two or three
VS
CADL vs. CRSP commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a Hold and CRSP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (CADL: $6.13 vs. CRSP: $56.18)
Brand notoriety: CADL and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 108% vs. CRSP: 77%
Market capitalization -- CADL: $336.53M vs. CRSP: $5.35B
CADL [@Biotechnology] is valued at $336.53M. CRSP’s [@Biotechnology] market capitalization is $5.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $115.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, both CADL and CRSP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 4 TA indicator(s) are bullish while CRSP’s TA Score has 7 bullish TA indicator(s).

  • CADL’s TA Score: 4 bullish, 5 bearish.
  • CRSP’s TA Score: 7 bullish, 1 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than CADL.

Price Growth

CADL (@Biotechnology) experienced а +9.86% price change this week, while CRSP (@Biotechnology) price change was -3.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

CADL is expected to report earnings on Mar 26, 2026.

CRSP is expected to report earnings on Feb 17, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($5.35B) has a higher market cap than CADL($337M). CADL YTD gains are higher at: 8.496 vs. CRSP (7.132). CADL has higher annual earnings (EBITDA): -20.74M vs. CRSP (-555.73M). CRSP has more cash in the bank: 1.92B vs. CADL (87M). CADL has less debt than CRSP: CADL (7.21M) vs CRSP (211M). CRSP has higher revenues than CADL: CRSP (35M) vs CADL (0).
CADLCRSPCADL / CRSP
Capitalization337M5.35B6%
EBITDA-20.74M-555.73M4%
Gain YTD8.4967.132119%
P/E RatioN/AN/A-
Revenue035M-
Total Cash87M1.92B5%
Total Debt7.21M211M3%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
79
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CADLCRSP
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 7 days ago
88%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CADL
Daily Signal:
Gain/Loss:
CRSP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHBAF10.80N/A
N/A
Chiba Bank, Ltd. (The)
TBBA6.65N/A
N/A
TEB Bancorp Inc.
PLQC65.00N/A
N/A
Plains Acquisition Corp.
SNYNF95.53-1.52
-1.57%
Sanofi
ASAIY6.75-0.22
-3.16%
Sendas Distribuidora S.A.

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with RXRX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
+4.61%
RXRX - CADL
46%
Loosely correlated
-2.49%
CYYNF - CADL
46%
Loosely correlated
N/A
RPTX - CADL
44%
Loosely correlated
+0.58%
RGNX - CADL
42%
Loosely correlated
-0.20%
CRSP - CADL
41%
Loosely correlated
+1.59%
More

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
+1.59%
BEAM - CRSP
72%
Closely correlated
+2.55%
RXRX - CRSP
68%
Closely correlated
-2.49%
ABSI - CRSP
62%
Loosely correlated
-2.65%
PRME - CRSP
60%
Loosely correlated
-2.80%
NTLA - CRSP
59%
Loosely correlated
+2.71%
More